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Synaptic GABA release prevents GABA transporter
type-1 reversal during excessive network activity
Leonid Savtchenko1, Maria Megalogeni1, Dmitri A. Rusakov1, Matthew C. Walker1 & Ivan Pavlov1
GABA transporters control extracellular GABA, which regulates the key aspects of neuronal
and network behaviour. A prevailing view is that modest neuronal depolarization results in
GABA transporter type-1 (GAT-1) reversal causing non-vesicular GABA release into the
extracellular space during intense network activity. This has important implications for GABA
uptake-targeting therapies. Here we combined a realistic kinetic model of GAT-1 with
experimental measurements of tonic GABAA receptor currents in ex vivo hippocampal slices
to examine GAT-1 operation under varying network conditions. Our simulations predict that
synaptic GABA release during network activity robustly prevents GAT-1 reversal. We test this
in the 0 Mg2þ model of epileptiform discharges using slices from healthy and chronically
epileptic rats and ﬁnd that epileptiform activity is associated with increased synaptic GABA
release and is not accompanied by GAT-1 reversal. We conclude that sustained efﬂux of
GABA through GAT-1 is unlikely to occur during physiological or pathological network activity.
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amma-aminobutyric acid (GABA) release and uptake
hold the key to the excitation–inhibition balance in the
brain. In addition to fast synaptic inhibition, GABA can
mediate a slower form of signalling through the persistent
activation of slowly desensitizing, high-afﬁnity extrasynaptic
GABAA receptors (GABAARs)1,2. This type of tonic GABAAR-
mediated conductance can be detected in the majority of
hippocampal and cortical neurons, in which it controls cell
excitability (for example, ref. 3). Importantly, the magnitude of
tonic conductance varies with local network activity4,5, depending
on the kinetic equilibrium between GABA release and uptake.
The resultant ﬂuctuations in extracellular GABA can, in turn,
regulate neuronal excitability and the synchronization of
neuronal networks6. Activity of GABA transporters therefore
plays a key role in regulating neuronal and network activity.
Four different subtypes of GABA transporters (GATs) have
been identiﬁed: GAT-1, 2, 3 and betaine GABA transporter
(corresponding in mice to GAT-1, 3, 4 and GAT-2, respectively).
The most abundantly expressed transporter in cortical structures
is GAT-1, which is primarily responsible for neuronal GABA
uptake. The other highly expressed cortical GABA transporter is
the predominantly glial GAT-3 (refs 7,8). Although transporter
molecules normally clear GABA from the extracellular space, they
can under certain conditions operate in the reverse mode9–13.
GAT-1 and GAT-3 are similar in their stoichiometry: each GABA
molecule (a zwitterion at physiological pH) is co-translocated
with two Naþ ions and one Cl  ion, thus making GABA
transport electrogenic. Therefore, the transmembrane
concentration gradients of Naþ,C l   and GABA, together with
the cell membrane potential, determine the direction of GABA
transport. How the efﬂux of GABA through reversal of its
transporters, in particular of neuronal GAT-1, contributes to the
extracellular GABA concentrations remains controversial.
Although there have been no direct measurements of the
reversal potential of GATs (EGAT) in brain tissue, indirect
experimental evidence and theoretical estimations suggest that
under baseline conditions transporters are near equilibrium,
reviewed in Richerson and Wu11. This is often used to argue
that GABA transporter reversal will occur with only moderate
cell depolarization and during trains of action potentials14,15.
It has been suggested that transporter-mediated GABA release
can thus provide compensatory feedback that suppresses
neuronal excitability through enhanced tonic inhibition during
epileptiform discharges16. However, during intense network
activity, there will also be an increased synaptic release of
GABA and consequently an increase in the extracellular
GABA concentration, which should stimulate GATs to
transport GABA into cells. Therefore, there remains signiﬁcant
uncertainty concerning the mode of action of GATs during
increased network activity.
In vivo, the inhibition of GABA transport during Kþ-induced
neuronal depolarization produces a larger increase in ambient
GABA concentration than does depolarization alone17. This
observation questions whether the efﬂux of GABA through
transporters indeed occurs during excessive neuronal ﬁring
(although astroglial release of GABA through GAT-3 has been
suggested18–20). Understanding the roles of neuronal GABA
transport in the face of increased network activity has important
implications for therapeutic targeting of neuronal GATs. For
example, if neuronal transporters indeed operate in the reverse
mode during epileptiform discharges, the use of the antiepileptic
drug tiagabine, which inhibits GAT-1, could have a paradoxical
pro-epileptic effect by decreasing seizure-related rises in GABA.
To address these issues, here we determine the impact of
network and neuronal activity both on GAT-1 operation and on
the extracellular GABA concentration. We explore the established
kinetic model of GAT-1 to argue, ﬁrst, that the transporter should
remain largely inactive at low ambient GABA concentrations and,
second, that the synaptic release of GABA during intense network
activity should robustly prevent GAT-1 from operating in the
reverse mode. We then demonstrate in acute slice experiments
that epileptiform discharges generated in the hippocampus of
either healthy or chronically epileptic rats markedly increase
synaptic GABA release thus preventing GAT-1 reversal. Together
these ﬁndings imply that hippocampal GAT-1 transports GABA
into neurons even in the face of increased network activity and
widespread neuronal depolarization.
Results
GAT-1 activity is sensitive to ambient GABA concentration.T o
examine the impact of membrane depolarization and extracellular
GABA concentrations ([GABA]e) on transporter operation in
steady state, we adapted a previously established kinetic model
of GAT-1 (ref. 21; Fig. 1a). Two important features emerged.
First, at the low [GABA]e observed experimentally under baseline
conditions both in vivo and in vitro22, the current–voltage
relationship of the transporter displayed marked outward
rectiﬁcation. Thus, there is little transporter activity when
the membrane potential (Vm) is below the spiking threshold.
Second, EGAT is highly sensitive to changes in ambient GABA
at low [GABA]e (Fig. 1b). Therefore, even a small increase in
[GABA]e readily pushes EGAT to suprathreshold Vm, suggesting
that GAT would be operating in the forward mode on detection
of GABA release by even depolarized neurons. Furthermore,
[GABA]e rises reduce the rectiﬁcation, thus further facilitating
GABA uptake (Fig. 1a).
Activity-dependent GABA release prevents GAT-1 reversal.T o
determine how GAT-1 operation relates to the presence of synaptic
GABA release, we adapted the above GAT-1 kinetic model for
simulations of GABA concentration dynamics in the extracellular
space and synaptic terminals. In the model, we placed 100 equally
spaced GABAergic synapses each attached to a 22-mm-long axon
segment in a 1,000-mm3 section of simulated hippocampal tissue,
in accord with previous estimates23. Each synapse had B1,200
GAT molecules and axonal segments had a linear density of 640
GATs mm 1 (ref. 24) (see Methods). Since the overall GABA
content in the brain remains relatively constant, we did not
consider GABA breakdown and synthesis mechanisms in our
model. We also assumed negligible impact of GABA diffusion
from neuronal soma on the average steady-state GABA levels in
synaptic terminals at the timescale of simulated events.
As expected, in agreement with previous ﬁndings in hippo-
campal neurons15,16,25, our simulations indicate that, in the
absence of synaptic GABA release, membrane depolarization
should increase the steady-state ambient GABA concentration
due to transporter-mediated efﬂux (Fig. 1c). These [GABA]e
increases may be limited by the amount of cytosolic GABA to
which the transporters are exposed. With the given overall GABA
content available inside the synaptic terminals, both the cytosolic
and the external GABA concentrations will be determined by
the ratio of the tissue volume fractions occupied by the
extracellular space and by the synaptic boutons. With an
estimated extracellular volume fraction of B0.14 (refs 26,27)
and realistic synaptic environment used in our simulations (see
Methods for details), the depletion of intracellular GABA seems
unlikely to prevent depolarization-induced [GABA]e rises.
However, decreasing the synapse density (and therefore the
total amount of GABA that can be distributed between synaptic
boutons and the extracellular space) reduced the effect of cell
depolarization on [GABA]e increases. The lower synapse density
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cytosolic GABA pool (Fig. 1c).
Simulations have shown that when synaptic GABA release is
intact, [GABA]e increases at all membrane potentials. This
increase is more pronounced for faster rates of release. Similar to
the above simulations, for any given rate of release, [GABA]e is
higher at more depolarized Vm (Fig. 1d). Expectedly, increasing
or decreasing the density of GAT-1 (ref. 28) shifted [GABA]e
downwards or upwards, respectively (Supplementary Fig. 1).
Our model explores two potential sources for extracellular
GABA, synaptic release and GAT-1 transporter-mediated efﬂux.
We therefore set out to determine the relationship between the
dynamics of GATs operation and [GABA]e either with or without
synaptic GABA release (Fig. 1e). As expected, in the absence of
GABA release, transporters remain inactive. Neuronal membrane
depolarization under these conditions leads to a brief reversal of
GABA transport. Transporter-mediated efﬂux, however, ceases
once a new steady-state GABA level is achieved. Sustained
synaptic release, on the contrary, leads to uninterrupted GABA
uptake (and a higher baseline [GABA]e) regardless of Vm.
GABA uptake during abnormal network activity. What
if GABA release is abruptly terminated while cells become
depolarized, which might potentially happen after or during a
seizure (when some interneurons may enter a depolarization
block or transiently exhaust their release machinery)? The model
predicts that these conditions do not lead to GAT-1 reversal, but
rather to decreased uptake and, eventually, to a complete
cessation of GABA uptake as GABA drops to its non-release
steady-state level. When synaptic GABA release persists during
depolarization, [GABA]e simply equilibrates to a new level after a
transient decrease in transporter inward current, and transporters
continue to operate in the forward mode (Fig. 1e).
Another common pathophysiological scenario is when
large increases in neuronal activity are accompanied by
intracellular Cl  accumulation29,30 and/or action potential-
associated Naþ inﬂux31. Still, even in the case of a substantial
and sustained increase of internal Cl  concentration ([Cl ]in)
and internal Naþ concentration ([Naþ]in) the model predicts
that GAT-1 is unlikely to reverse in the face of synaptic release
(Supplementary Fig. 2a, Methods).
One important consequence of higher internal Cl  and Naþ
is that the efﬁciency of the transporter operation (in terms of
transmembrane ﬂuxes) in the forward mode becomes profoundly
reduced (Supplementary Fig. 2b). Also, as neurons become loaded
with Cl  and Naþ, the transporters will not be able to maintain
the extracellular GABA concentration in the nM range at
physiologically relevant cell membrane potentials (that is, above
 80mV, white area in Supplementary Fig. 2c). Furthermore,
because an intracellular rise in Cl  and Naþ causes the increase
in the steady state [GABA]e, cytosolic GABA depletion on
depolarization appears to be more pronounced (Supplementary
Fig. 2d). This, however, has no bearing on the prevalence of direct
transporter mode.
Since the majority of neuronal GAT-1 molecules are located on
the axons and synaptic terminals of interneurons7, their
operation may also be affected by large transient membrane
depolarizations accompanying each round of action potential-
dependent synaptic GABA release. To evaluate the impact of such
a mechanism, we compared [GABA]e attained when transporters
experienced 2-ms-long voltage spikes (120mV in amplitude)
approximating action potentials, with that in the absence of
spikes (Fig. 1f). The release rate in each synapse was set to half
that of the rate of action potentials, to mimic a release probability
of 0.5 observed in hippocampal interneurons32. Varying ﬁring
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Figure 1 | GAT-1 activity and [GABA]e simulations. (a) Current–voltage
relationship of the steady-state GAT-1-mediated current (JGAT,
moleculess 1; negative values—forward mode, positive values—reverse
mode) at different concentrations of extracellular GABA (in mM).
(b) Dependence of GAT-1 reversal potential (EGAT) on the concentration of
extracellular GABA. (c) Membrane potential dependence of the steady-
state cytosolic ([GABA]cyt; red symbols) and extracellular GABA
concentrations ([GABA]e; black symbols) in the absence of synaptic
release. Filled circles—for 100 synapses, open circles—for 10 synapses.
(d) Membrane potential dependence of the steady-state [GABA]cyt and
[GABA]e at various rates of synaptic release. (e) The effect of
depolarization on the dynamics of GAT-1 operation and [GABA]e with (red)
and without (black) synaptic GABA release. (f) The effect of presynaptic
depolarization due to action potentials on the accumulation of extracellular
GABA. Inset: simulated voltage changes. (g) Left: an increase in [GABA]e
due to presynaptic spike-induced depolarization at different ﬁring
frequencies (% change compared with [GABA]e in the absence of
simulated presynaptic action potentials). Right: GAT-1 current dynamics at
160Hz presynaptic ﬁring frequency.
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interneurons), we found that [GABA]e was increased by the
presence of presynaptic action potentials; and the maximal
change (55% increase) in [GABA]e was at 160Hz (Fig. 1g). This
suggests that voltage-dependent changes in the efﬁciency of
GABA transport may considerably alter [GABA]e at high rates of
release. However, even the maximal effect of action potential-
dependent depolarization on extracellular GABA concentration
did not trigger reversed GAT-1 transport (Fig. 1g).
Our simulations, therefore, suggest that synaptic GABA release
results in GAT-1 operating in forward mode even during
neuronal depolarization and rapid repetitive presynaptic ﬁring.
The prediction is therefore that during extremes of network
activity, such as epileptiform activity, the transporters should not
reverse. We tested this experimentally in the acute hippocampal
slice preparation.
GABA sensed by pyramidal neurons depends on GAT-1 activity.
The relative contribution of the main cortical GABA transporters
GAT-1 (neuronal) and GAT-3 (glial) to GABA uptake varies
depending on brain region and cell type5,17,33,34.W eﬁ r s tt e s t e d
their impact on [GABA]e in the hippocampal area CA1 using GAT
inhibitors (Fig. 2). Whole-cell patch-clamp recordings were
performed from pyramidal neurons in the presence of CGP55845
(1mM), NBQX (20mM), APV (50mM) and tetrodotoxin (1mM) to
block GABAB and ionotropic glutamate receptors, as well as action
potential-dependent GABA release. Neurons were held at
 70mV and recorded using high Cl  internal solution (see
Methods). Application of the GAT-1 inhibitor SKF89976A
(30mM) produced a signiﬁcant (Holm–Bonferroni correction)
inward shift of holding current (DIhold;  27.7±4.7pA; n¼11,
P¼0.0002, paired t-test; Fig. 2b,c). No apparent signiﬁcant
(Holm–Bonferroni correction) changes in Ihold were observed on
application of the GAT-3 inhibitor SNAP5114 (100mM;
 2.2±1.9pA; n¼5, P¼0.3, paired t-test; Fig. 2a,c), conﬁrming
that under baseline conditions, with GAT-1 operational,
GAT-3 has little effect on the GABA concentration detected by
principal neurons in the hippocampus17,19. The same
concentration of SNAP5114 applied following inhibition of
the GAT-1 transporter resulted in a rapid signiﬁcant
(Holm–Bonferroni correction) increase in the inward current,
indicating that GAT-3-mediated GABA uptake regulates [GABA]e
around pyramidal cells in the absence of GAT-1 activity (DIhold:
 113.7±17.8pA; n¼6, P¼0.0014, paired t-test compared with
SKF89976A alone; Fig. 2b,c).
Epileptiform bursts are associated with massive GABA release.
To address whether GABA transport reverses during extremes of
network activity, we induced regular recurrent epileptiform dis-
charges by using Mg2þ-free artiﬁcial cerebrospinal ﬂuid
(aCSF)35. Under these conditions, the majority of slices developed
stereotypical spontaneous interictal-like ﬁeld potential bursts that
persisted at a stable frequency for at least 1h (Fig. 3a). To
monitor the GABAAR-mediated currents in neurons during on-
going epileptiform activity, pyramidal cells were voltage clamped
at 0mV, close to the reversal potential of glutamate receptor-
mediated currents, using an intracellular solution containing
8mM Cl  (calculated Cl  reversal potential, ECl¼ 72mV).
Simultaneous ﬁeld potential and whole-cell recordings revealed
that each ﬁeld potential burst was accompanied by a concomitant
GABAAR-mediated transient (Fig. 3b,c). These GABAAR-
mediated currents in pyramidal cells reached up to 1.5–2nA in
amplitude, while, between bursts, spontaneously occurring
inhibitory post-synaptic currents (IPSCs) were two orders of
magnitude smaller. We also noted that ﬁeld potential recordings
underestimate the duration of underlying burst discharges as
these large, interictal-like event-associated GABAergic currents
were considerably longer than bursts detected by extracellular
electrodes, and often burst-associated large IPSCs were heralded
by a ﬂurry of smaller amplitude IPSCs at high frequencies
(Fig. 3c).
Intense GABA release associated with epileptiform activity was
also reﬂected in the rapid accumulation of extracellular GABA on
inhibition of GAT-1 and GAT-3. The rate of increase of the tonic
GABAAR-mediated current was signiﬁcantly faster in ‘epileptic’
slices than in quiescent ones (n¼4 for each condition, P¼0.004;
t-test, Fig. 3d). Blocking action potential-mediated neurotrans-
mitter release and GABAARs, with tetrodotoxin and picrotoxin
respectively, at the end of each experiment revealed larger tonic
GABAAR currents in slices in which epileptiform activity was
generated (P¼0.016, t-test). Co-application of both GAT
inhibitors almost completely abolished epileptiform discharges.
This effect was partly reversible on drug washout (Fig. 3e).
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population discharges in the hippocampus are accompanied by
prolonged activation of interneurons leading to a marked increase
in GABA release.
GAT-1 inhibition does not reduce tonic GABAARc o n d u c t a n c e .
Does the tonic current in ‘epileptic’ slices result from increased
synaptic GABA release or from the reversal of GABA transport? In
the latter case, inhibiting GATs should decrease the extrasynaptic
GABA concentrations and thus reduce the tonic conductance in
hippocampal neurons. In contrast, application of SKF89976A
resulted in an outward shift in Ihold (Fig. 4a; 27.9±7.1pA, n¼6,
P¼0.011, paired t-test) indicating that inhibition of GAT-1
increases GABAAR-mediated conductance in hippocampal neu-
rons under conditions that promote the occurrence of epileptiform
discharges. The effect of SKF89976A on the Ihold is qualitatively
similar to that in the normal Mg2þ aCSF (that is, in the absence of
epileptiform activity; 15.7±3.4pA, n¼5, P¼0.0102, paired t-test;
Supplementary Fig. 3). This increase is likely to be due to the
accumulation of synaptically released GABA. To test this, we
preincubated slices in 1mM concanamycin and performed
recordings in the presence of tetrodotoxin, that is, in conditions
with no vesicular GABA release. Indeed, GAT-1 inhibition in these
experiments had little effect on the Ihold, reﬂecting the lack of
detectable GABA uptake in the absence of synaptic neuro-
transmission (Fig. 4b).
We also noted that the inhibition of glial transporter GAT-3 in
slices generating epileptiform activity did not reduce tonic
GABAAR conductances either. If anything, SNAP5114 produced
a small, statistically insigniﬁcant outward shift in the Ihold
(3.5±2.8pA; n¼5; P¼0.22, paired t-test; Supplementary
Fig. 4a), suggesting that GAT-1 activity remains the major factor
that determines [GABA]e detected by principal cells under
epileptogenic conditions.
The lack of an inward shift in Ihold (that is, any decrease in
GABA-mediated tonic current) measured between epileptiform
bursts following GAT-1 or GAT-3 inhibition argues against a
signiﬁcant overall contribution of GAT-mediated GABA release
to the accumulation of ambient GABA in ‘epileptic’ slices. GAT
reversal, however, may still occur transiently, during pathological
discharges. To test if this is the case, we compared the kinetics of
ﬁeld potential burst-associated large GABAAR transients with and
without GABA transporters inhibition. It has been shown that,
following concurrent activation of multiple release sites, for
example, during evoked release, GABA uptake limits the
activation of peri- and extrasynaptic GABAARs36. Thus, GAT
blockade would be expected to prolong GABAAR-mediated
currents during epileptic discharges if transporters operate in
forward mode. SKF89976A considerably increased the duration
of GABAAR-mediated currents (Fig. 4c), indicating that GAT-1 is
actively engaged in clearing GABA from the extracellular space
during burst discharges. This was evident not only in slices from
control animals, but also in slices from chronically epileptic rats
(Fig. 4d). The increase in the decay kinetics of the GABAAR-
mediated transients was similar in both groups, suggesting that
epileptogenesis is not associated with compensatory reversal of
GAT-1 operation. In line with the limited contribution of GAT-3
to the level of ambient GABA detected by hippocampal pyramidal
neurons in the presence of functional GAT-1 uptake, application
of SNAP5114 did not alter the decay of large GABAAR transients
(n¼4, the area under GABAAR-mediated transients in
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Supplementary Fig. 4b).
Our in vitro and in silico experiments thus argue against the
reversal of GAT-1 during epileptiform activity and suggest that
increased vesicular GABA release during intensive ﬁring of
interneurons prevents GAT-1-mediated GABA efﬂux.
Discussion
GABA transporters in neurons and astrocytes operate close to
their equilibrium potential and therefore can reverse with
depolarization potentially generating non-vesicular release of
the neurotransmitter into the extracellular space11,12. Such
observations have prompted the idea that transporter-mediated
GABA efﬂux (reversal mode) may occur following Kþ or
glutamate-induced cell membrane depolarizations that
accompany increased network activity and, therefore, can
provide additional inhibition during epileptic discharges.
However, this conjecture has remained speculative, mainly
because electrophysiological experiments to support this have
assessed GAT-1 reversal in the absence of synaptic activity15,16,25,
which deviates from the scenario involving physiological or
pathophysiological increases in brain network activity.
Our previous work using in vivo microdialysis has
demonstrated that concurrent inhibition of GABA transport
and Kþ-induced neuronal depolarization induces a several-fold
larger increase in [GABA]e than does Kþ-induced depolarization
alone, arguing against transporter-mediated efﬂux of GABA17.
Here we examined this issue further by using detailed
computational modelling and experimental recordings from
acute hippocampal slices.
Using outside-out ‘sniffer’ patches to detect extracellular
GABA in vitro and quantitative microdialysis in vivo,w e
previously found that the extracellular GABA concentration is
maintained at a very low level and is likely to be less than 200nM
(ref. 22). This is in line with estimates of extracellular GABA in
slices based on tonic GABAAR-mediated currents37, but
somewhat lower than 0.8–2.4mM suggested by early
microdialysis studies38–41. However, the use of anesthesia
during measurements and a short time between the probe
implantation and sample collection in the latter studies may have
overestimated [GABA]e. Conservative estimates of cytosolic
GABA, Naþ and Cl  concentrations used in the kinetic model
here (see Methods) resulted in [GABA]e close to that measured
above: B200nM at an assumed resting membrane potential of
 70mV (for example, see refs 42,43).
An important conclusion that follows from our simulations is
that even in the absence of release, the reverse mode of GAT-1
operation in the hippocampus can occur only transiently, simply
because the presence of newly released GABA will halt the reverse
mode. In other words, on sustained depolarization, these
transporters will only brieﬂy work in reverse until [GABA]e has
reached the steady-state level for the new Vm. Once this new level
of extracellular GABA is reached, transporters will remain
inactive (dormant). Under continuous uptake triggered by
synaptic activity, the sustained subthreshold depolarization is
unlikely to trigger even a transient reversal. Furthermore, GABA
transporter reversal does not occur even when presynaptic
terminals populated with GAT-1 transporters generate trains of
action potentials. Although [GABA]e in the presence of
presynaptic spikes will be higher, this simply reﬂects the reduced
GABA uptake during increased action potential-dependent
GABA release. This sequence of events involving reduced GABA
uptake suggests that high frequency interneuronal ﬁring can
enhance extrasynaptic spillover of GABA thus boosting activation
of perisynaptic GABAB receptors44.
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Figure 4 | GAT-1 does not reverse during epileptiform activity. (a)
Changes in tonic GABAAR-mediated currents in CA1 pyramidal neurons
following application of SKF899976A during ongoing epileptiform activity
(n¼6; PTX, picrotoxin; TTX, tetrodotoxin; error bars, s.e.m.). (b) The effect
of GAT-1 inhibition on tonic GABAAR-mediated currents in CA1 pyramidal
neurons in the absence of synaptic GABA release (slices preincubated in
1mM concanamycin; n¼6; error bars, s.e.m.). (c,d) Mean normalized traces
of GABAAR transients (grey: s.e.m.) show that SKF89976A similarly
prolongs burst-associated GABAAR transients in pyramidal neurons from
control (c; area under the curve, AUC, increases from 88.8±18.2 to
188.6±53.9ms; n¼6; P¼0.038, paired t-test) and epileptic hippocampi
(d; AUC increase from 107.9±21.6 to 173.3±24.8ms; n¼8; P¼0.0012,
paired t-test). Bars, mean; error bars, s.e.m.; circles, individual experiments.
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GABA release the reversal of GABA transport due to membrane
depolarization is unlikely, mainly because synaptically released
GABA contributes signiﬁcantly to [GABA]e (in vivo blocking
action potential-dependent release decreases it by B75% (ref. 17)).
We also note that the use of EGAT in determining the mode of
GAT-1 operation is limited, because this parameter will
dynamically change depending on the ﬂuctuations of GABA,
Naþ and Cl , both inside and outside cells.
A number of clinical and animal studies of ictogenesis have
shown that the increased excitatory drive may mask a massive
recruitment of inhibitory neurons during both ictal and interictal
events45–48. Indeed, here we demonstrate that epileptiform
activity is accompanied by intense synaptic GABA release.
Consistent with theoretical predictions, we did not observe a
reduction in tonic GABAAR-mediated currents on blockade of
neuronal GABA transporters. Inhibition of GAT-1 had
qualitatively similar actions on picrotoxin-sensitive tonic
currents under conditions designed to promote epileptiform
activity and in quiescent conditions, suggesting that these
transporters continue to operate in the forward mode despite
hyperexcitable conditions and increased network activity. In
contrast, the inhibition of GAT-1 in slices preincubated in
concanamycin, and thus void of synaptic release, did not lead to
increased tonic GABAAR currents. This argues that the enhanced
synaptic GABA release, which accompanies epileptiform
discharges in 0 Mg2þ, compels the transporters to operate in
the forward mode.
Astroglia have been suggested to be an important source of
extracellular GABA in various brain regions, and reversed GABA
transport20,49–52 as well as channel-mediated release53 have been
implicated. In contrast to, for example, thalamus, where GAT-3 is
abundantly expressed33,54, and in line with previous studies17,33,
our results indicate that the GABA concentration in the
hippocampus detected by pyramidal cells is primarily controlled
by GAT-1. GAT-3 activity, on the other hand, in
the presence of GAT-1-mediated uptake does not have a
detectable impact on the tonic GABAA receptor-mediated
conductance in hippocampal pyramidal neurons. Although
spatially segregated action of GAT-3 cannot be excluded5, and
our data do not allow us to unequivocally rule out GAT-3 reversal
during epileptic discharges18,19, reversed uptake by GAT-3 would
be expected to further facilitate the forward mode of GAT-1
operation.
An alternative mechanism for GAT-1 reversal may involve the
collapse of Naþ gradient, which drives the transporters in the
forward mode, and a gradual accumulation of Cl  following
extensive seizure activity, for example, see refs 29,30. However,
such ionic changes will in the ﬁrst place reduce the efﬁcacy of the
GABA uptake; and our simulations show that in the presence of
synaptic release the reversal of GAT-1 in this case is still unlikely.
One prediction from these simulations is that impaired Cl 
extrusion in chronic epilepsy55 may result in an increased
[GABA]e, which in turn could partly explain why tonic currents
are not only maintained, but often are increased in epileptic
animals56,57. Similarly, in the neonatal brain, [GABA]e may be
maintained at higher levels due to developmental differences in
the Cl  homeostasis55.
Furthermore, our results show an increased GABAergic
synaptic drive onto CA1 pyramidal neurons in 0 Mg2þ perfusion
solution, providing indirect evidence that Naþ accumulation in
interneurons is limited, as it would be expected to manifest itself
in the abortion of action potential-dependent synaptic GABA
release. Indeed, interneurons, especially fast spiking cells, display
a higher Naþ/Kþ-ATPase activity than that of pyramidal
neurons, arguably to facilitate high frequency ﬁring58. Thus,
although GAT reversal due to [Naþ]in accumulation is plausible
under extreme pathological conditions (when neuronal Naþ/
Kþ-ATPase fails to maintain low intracellular Naþ
concentrations59, or in the rare circumstance when GAT-1 and
GABA are expressed by excitatory neurons60), physiologically
relevant network activity is unlikely to be associated with such a
failure.
Several recent studies have proposed that certain types of
interneurons may cease ﬁring during epileptic discharges;
however, the transition of interneurons into depolarization
block is usually preceded by a period of their hyperactivity61,62.
Recordings from patients with epilepsy, as well as animal
studies, have also demonstrated early recruitment of
interneurons before seizure precipitation46,48 or at the
beginning of interictal discharges62. In this scenario (Fig. 1e),
ambient GABA elevation due to intense synaptic release before
the reduction in GABAergic neurotransmission will still be
expected to counteract the reversal of GATs. However, it is worth
noting that many interneurons do not display depolarization
block, and in our experience even those slices that generate
prolonged ictal-like activity display a sustained increase of the
GABAergic drive onto pyramidal cells. Furthermore, in the
present study, we did not observe GAT-1 reversal during
pathological discharges in the hippocampus from chronically
epileptic animals. Somewhat counterintuitively, our simulations
suggest that reducing the number of GABAergic synapses due to
the loss of interneurons commonly observed in epilepsy, for
example, refs 63,64, should make GAT-1 reversal even less likely
by decreasing the ratio of volume fraction occupied by
GABAergic terminals and the extracellular space.
In conclusion, our results argue that, with synaptic GABAergic
neurotransmission intact, GAT-1 operation in the reverse mode is
unlikely to occur even during extreme neuronal activity. When
GABAergic transmission fails, the transporter could reverse but
only transiently. Thus, extracellular GABA concentrations in the
brain are set, depending on the level of network activity, by
synaptic GABA release and the rate of GABA uptake, rather than
by GAT-1-mediated efﬂux.
Methods
Either 3–4-week-old or adult male Sprague–Dawley rats (Harlan Laboratories Inc,
Bicester, UK) were used in the experiments. Animals were kept under standard
housing conditions with a 12-h light–dark cycle and free access to food pellets and
drinking water. Animal procedures were subject to local ethical approval and
followed the UK Home Ofﬁce Animal (Scientiﬁc Procedures) Act, 1986.
In vitro electrophysiology. In vitro electrophysiological recordings were per-
formed in acute hippocampal slices prepared from 3–4-week-old control rats and
adult chronically epileptic and sham-control animals. After decapitation, brains
were rapidly removed and hippocampi were dissected. Transverse hippocampal
slices (350-mm thick) were cut with a Leica VT1200S vibratome (Germany) in an
ice-cold sucrose-based solution containing (in mM): sucrose (70), NaCl (80), KCl
(2.5), MgCl2 (7), CaCl2 (0.5), NaHCO3 (25), NaH2PO4 (1.25) glucose (22), bubbled
continuously with 95% O2þ5% CO2 to yield a pH of 7.4. Slices were allowed to
recover in a sucrose-free aCSF solution (in mM): NaCl (119), KCl (2.5), MgSO4
(1.3), CaCl2 (2.5), NaHCO3 (26.2), NaH2PO4 (1), glucose (22), bubbled with 95%
O2 and 5% CO2 in an interface chamber for at least 1h at room temperature before
being transferred to a submerged recording chamber. Modiﬁed aCSF (nominally
0mMMg 2þ and 5mM Kþ) was used to induce epileptiform activity. To facilitate
rapid generation of epileptiform discharges slices were perfused with the solution
on both sides. All recordings were done at 32C. GABAB receptors were blocked in
all experiments by 1mM CGP55845.
Field potential recordings from stratum pyramidale were performed with 1–
2MO glass electrodes ﬁeld with aCSF. Visualized whole-cell voltage-clamp
recordings were performed from CA1 pyramidal neurons using infrared
differential interference contrast imaging system. Recording pipettes (3–5MO)
were ﬁlled either with a high Cl  internal solution containing (in mM): CsCl
(120), HEPES (10), EGTA (2), NaCl (8), MgCl2 (0.2), Mg-ATP (2), Na-GTP (0.3),
QX-314 Br  salt (5), pH 7.2, 290 mOsm (experiments in Fig. 2, neurons voltage
clamped at  70mV), or with a low Cl  internal solution, containing (in mM):
Cs-methanesulfonate (120), HEPES (10), EGTA (0.2), NaCl (8), MgCl2 (0.2),
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whole-cell recordings; neurons held at 0mV). Recordings from cells voltage
clamped at  70mV were performed in the presence of AMPA/kainate and
NMDA receptor blockers NBQX (25mM) and D-AP5 (50mM) respectively. Naþ-
channel blocker tetrodotoxin (1mM) was also included in the perfusion solution. In
the absence of glutamate receptor blockers (when epileptiform activity was
induced), GABAAR-mediated currents were recorded from neurons voltage
clamped at 0mV (close to the reversal potential of glutamatergic currents) using
low Cl  internal solution. To prevent the contribution of NMDA receptors
MK801 (1mM) was included in the recording pipettes in these experiments. Tonic
GABAAR-mediated currents were measured as changes in holding current 10min
following application of GAT inhibitors or after adding GABAAR antagonist
picrotoxin (100mM). To avoid bias due to increased frequency of synaptic currents
in recordings from slices with epileptiform activity, the method of Gaussian ﬁt was
used to determine the mean holding current4. To establish the effect of GAT
inhibitors on the decay of burst-associated GABAAR-mediated transients,
recurrent events were identiﬁed using the threshold-detection protocol in Clampﬁt
10.0 set at least twice exceeding the size of the background activity. At least 20
events were averaged for each condition.
Series resistance (Rs) was monitored throughout the experiment using a –5-mV
step command. Cells showing a 420% change in Rs, or values 425MO,o ra n
unstable holding current, were rejected. Recordings were obtained using a
MultiClamp 700B ampliﬁer (Axon Instruments, Foster City, CA, USA), ﬁltered at
4kHz and digitized at 10kHz. Data acquisition and off-line analysis were
performed using WinEDR 3.0.1 (University of Strathclyde, Glasgow, UK) and
Clampﬁt 10.0 (Molecular Devices Corporation, USA) software.
GABA transporter inhibitors, tetrodotoxin, glutamate and GABA receptor
blockers were purchased from Tocris Cookson (Bristol, UK) and Ascent Scientiﬁc
(North Somerset, UK).
Two-tailed paired and unpaired Student’s t-test was used for statistical analysis
of electrophysiological data. Differences were considered signiﬁcant when Po0.05.
A Holm–Bonferroni correction for multiple comparisons was used to adjust the
level of signiﬁcance for data presented in Fig. 2. Data are shown as mean±s.e.m.
Perforant path (PP) stimulation epilepsy model. Chronic epilepsy was induced
in male Sprague–Dawley rats (290–350g) rats as described previously65. Rats were
operated under isoﬂurane anesthesia to implant a bipolar stimulating electrode and
a unipolar recording electrode into the right angular bundle (8.1mm anterior and
4.4mm lateral to bregma) and dentate gyrus ( 4.4mm anterior and  2.5 lateral
to bregma), respectively. A silver earth electrode was positioned subcutaneously
and electrodes were mounted into a six-channel plastic pedestal and secured using
skull screws and dental cement (Kemdent, UK). To ensure the correct location of
the electrodes, stimulation of the PP was performed while monitoring ﬁeld
potential responses from the dentate gyrus. After at least 7 days of recovery status
epilepticus (SE) was induced by 50ms pulses continuously applied to the PP at
20Hz for 2h. Animals displaying no seizures were excluded from experiments. SE
was allowed to continue in the absence of stimulation for 3h and was then
terminated by intraperitoneal administration of diazepam (o20mgkg 1).
Animals were then rehydrated with saline (0.9%w/v, subcutaneously). Chronically
epileptic rats were used for in vitro electrophysiology 4–5 weeks after SE induction.
Sham-control animals underwent similar surgery procedures without SE induction.
Modelling. Steady-state and pre-steady-state GAT-1 transmembrane currents
were simulated using a previously published kinetic scheme21. All parameters of
the state transitions were the same as in the original publication. Pascal 7.0 code
was used for numerical integration of the set of differential equations. Steady-state
values were calculated using the Gauss–Seidel method (also known as the
Liebmann method). Computer code used for simulations is available on request.
[GABA]e dynamics were calculated in the volume of 1 103mm3 using
PASCAL model according to the following equation:
d½GABA e
dt
¼ n
X
k
Q
aV
d t  tk ðÞ  
JGAT1 Ss Trs ½  þ Sa Tra ½  ðÞ
aV
 !
where d is a delta function.
Simulated extracellular space was populated by n uniformly distributed
synapses. Each synapse independently released Q¼3,000 GABA molecules66 at the
time tk¼f 1, where f is the frequency of synaptic release. Each terminal was
considered as a half-sphere with a radius of 0.25mm, and was connected to a
22-mm-long segment of an axon. Synaptic surface, Ss, was assumed to have
Trs¼3,000 GAT-1 moleculesmm 2 resulting in B1,200 GATs per bouton; axon
segments had Tra¼640 transporters per mm length, Sa (ref. 24). The density of
GABAergic terminals was chosen to match experimentally observed values23.W e
used volume fraction of extracellular space a¼0.14 similar to the values observed
in the CA1 region of the hippocampus26,27. Following each release event, GABA
molecules instantly ﬁlled simulated extracellular space uniformly increasing GABA
concentration. The model made no assumptions regarding the dynamics of
cytosolic–vesicular GABA exchange, and to preserve the overall GABA content any
increase in the extracellular GABA was accompanied by a corresponding decrease
in the cytosolic GABA. The rate of GABA concentration change depended on the
current generated by m¼([Ss Trs]þ[Sa Tra]) molecules of GAT-1, mJGAT1.
Depending on the direction of the current, [GABA]e either increased or decreased.
It was assumed that a single charge transfer by the transporter corresponds to the
translocation of one GABA molecule. Computations were carried out using a 64-
core in-house computer cluster67 with software environment optimized in
collaboration with Sitrus LLC (Boston).
Voltage changes due to presynaptic spiking were simulated as step-like jumps of
120mV in amplitude each having a duration of 2ms at the frequency of fAP.
Release probability of GABAergic synapses was assumed to be 0.5 (ref. 32), so the
frequency of release was twice lower than the frequency of spiking.
Internal concentrations of [Naþ]in¼7mM and [Cl ]in¼7mM were chosen
to fall within physiologically relevant range of 5–10mM estimated for neurons, for
example, refs 29,68–70; external concentrations of these ions were as in the aCSF
used in the experiments ([Naþ]e¼146.2mM, [Cl ]e¼126.5mM). In some
simulations (Supplementary Fig. 2), [Cl ]in was increased to 30mM (to mimic
proposed seizure-induced Cl  accumulation29,30) and [Naþ]in to 15mM (to
account for the spike-associated inﬂux31; presynaptic terminals may fail to sustain
action potential generation at higher values in the Hodgkin–Huxley model).
Cytosolic GABA concentration in cortical neurons remains unknown and values
around 2mM are considered to be justiﬁed15. We have considered [GABA]cyt as a
dynamically changing concentration calculated as follows:
GABA ½  initial cyt  GABA ½  cyt
   .
GABA ½  initial e  GABA ½  e
  
¼Vr;
where VrB42 is the ratio between the extracellular and intracellular space. The
initial cytosolic GABA concentration, [GABA]initial cyt, was set at 2mM. Assuming
[GABA]e¼100nM (ref. 22), this resulted in EGAT¼ 74.25mV (close to the
resting membrane potential of  70mV used in our simulations). We have also
tested GAT-1 kinetics with intracellular GABA ranging between 1 and 4mM.
Altering cytosolic GABA concentration did not change the shape of the current–
voltage relationship of GAT-1 and EGAT sensitivity to extracellular GABA
(Supplementary Fig. 5a,b). The results of our simulations suggest that, for a given
subthreshold, Vm (for example,  70mV), elevating [GABA]cyt will result in an
increased basal extracellular GABA level (that is, the equilibrium achieved in the
absence of synaptic release Supplementary Fig. 5c).
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